| Literature DB >> 32972421 |
Louise Lester1, Michelle M Haby2,3, Evelina Chapman4, Tanja Kuchenmüller5.
Abstract
BACKGROUND: The Evidence-informed Policy Network (EVIPNet) is one of the key mechanisms introduced by WHO to reduce the research-to-policy gap. EVIPNet Europe was launched in 2012. We evaluated the performance and achievements of EVIPNet Europe with the overall aims (1) to inform future developments and strategic planning of EVIPNet Europe and (2) to contribute to the evidence base for organisational knowledge translation activities by sharing the lessons learnt.Entities:
Keywords: Knowledge translation, evidence-informed policy, network, evaluation
Mesh:
Year: 2020 PMID: 32972421 PMCID: PMC7513318 DOI: 10.1186/s12961-020-00612-x
Source DB: PubMed Journal: Health Res Policy Syst ISSN: 1478-4505
Fig. 1EVIPNet’s networked governance structure. Source: WHO Regional Office for Europe [25]
Fig. 2EVIPNet Europe Theory of change: research uptake and policies
EVIPNet Europe evaluation questions and sub-questions
| Evaluation questions | Evaluation sub-questions |
|---|---|
| 1. To what extent are the EVIPNet Europe objectives justified in relation to the current needs in countries? (Is EVIPNet Europe needed and accepted by member countries?) | a. How effective is the communication in both directions between the EVIPNet Europe Secretariat and the members of EVIPNet Europe? b. To what extent do member countries recognise and support EVIPNet Europe’s strategies, objectives, mandate and function? c. What factors at country level have facilitated or hindered the creation of stable and sustained research-to-policy activities and environments in EVIPNet Europe member countries? |
| 2. Has EVIPNet Europe produced the expected results? (Is EVIPNet Europe achieving its objectives?) | d. How actively are EVIPNet Europe members engaged with the Network and participating in its activities at WHO Secretariat and country team levels? e. To what extent does EVIPNet Europe increase effective joint working, networking, collaboration and sharing of lessons between individuals and organisations at national, regional and international levels? f. What are the resources (human, financial, time and skills) invested in the work of EVIPNet Europe at WHO Secretariat and country team levels? g. To what extent have EVIPNet Europe and country teams developed skills and changed knowledge, attitudes and behaviours to use evidence in policy-making? |
| 3. Does the development/implementation of EVIPNet Europe contribute to reaching higher-level objectives (such as KT and EIP)? (What are the outcomes of EVIPNet Europe?) | h. What are the accountability mechanisms for EVIPNet Europe (Secretariat and member countries) to measure the progress of EIP? i. To what extent have EVIPNet Europe’s portfolio of EIP tools been used by country teams to influence changes in policy? j. Does EVIPNet Europe fill a niche in the European health policy environment? k. To what extent do Network member countries value, promote and advocate for EVIPNet Europe’s function and EIP approaches throughout the WHO European Region? l. How have the relationships, contacts and exchanges created by EVIPNet Europe influenced the country EIP environment? |
EIP evidence-informed policy-making, EVIPNet Evidence-Informed Policy Network, KT knowledge translation
Summary of data collected for WHO Secretariat and country-level evaluations
| Method | Number of participants (participated/invited) | Date conducted |
|---|---|---|
| WHO Secretariat | 30 documents | Aug–Sept 2018 |
| Country team A | 11 documents | Aug–Sept 2018 |
| Country team B | 11 documents | Aug–Sept 2018 |
| – | 4 June 2015–13 July 2018 | |
| WHO country office staffa | 12/20 | Sept–Oct 2018 |
| National Championsb | 11/20 | Sept–Oct 2018 |
| WHO Secretariat | 8/10 | Aug–Sept 2018 |
| Country team A | 3/4 | Aug–Sept 2018 |
| Country team B | 5/5 | Aug–Oct 2018 |
| Country team A | 3/3 | Sept–Oct 2018 |
| Country team B | 2/3 | Sept–Oct 2018 |
a One EVIPNet Europe member country does not have a WHO country office
b One EVIPNet Europe member country did not have an eligible national champion available at the time of the evaluation to invite
Progress of EVIPNet Europe member countries at the time of the evaluation
| Country code and date of joining EVIPNet Europe | Progress made toward a KTP: Evidence-informed policy-making documents produced |
|---|---|
| A. 2013 | Situation analysis in development |
| B. 2013 | Evidence brief for policy (2016) Situation analysis in development |
| C. 2013 | Situation analysis developed and published in a peer-reviewed journal (2018) Evidence brief for policy, policy dialogue (2017), establishing KTP |
| D. 2013 | EVIPNet Europe national launch workshop took place Situation analysis developed and deliberated at a stakeholder workshop (in the publication process) Evidence brief for policy in development |
| E. 2013 | EVIPNet Europe national launch workshop took place Situation analysis in development Evidence brief for policy on hold |
| F. 2013 | EVIPNet Europe national launch workshop took place Situation analysis and Evidence brief for policy in development |
| G. 2013 | EVIPNet Europe national launch workshop took place Situation analysis in development Evidence brief for policy, policy dialogue (2017) |
| H. 2013 | EVIPNet Europe national launch workshop took place Situation analysis in development Evidence brief for policy, policy dialogue (2017) Second evidence brief for policy in development |
| I. 2013 | Rapid response report (2017)Evidence brief for policy in development |
| J. 2013 | EVIPNet Europe national launch workshop took place Situation analysis (2017) Evidence brief for policy in development, establishing KTP |
| K. 2013 | EVIPNet Europe national launch workshop took place Situation analysis developed and deliberated at a stakeholder workshop |
| L. 2013 | Evidence brief for policy in development |
| M. 2013 | |
| N. 2016 | |
| O. 2016 | Round table discussion (2017) Evidence brief for policy in development |
| P. 2016 | |
| Q. 2016 | EVIPNet Europe national launch workshop took place Situation analysis and Evidence brief for policy in development |
| R. 2016 | Situation analysis and Evidence brief for policy in development |
| S. 2016 | EVIPNet Europe national launch workshop took place Situation analysis initiated |
| T. 2018 | Evidence brief for policy development initiated |
| U. 2018 |
a Note that only country-specific activities are included in the table. All of the countries will also have participated in multi-country meetings such as capacity-building workshops
EVIPNet Evidence-Informed Policy Network
Themes and sub-themes identified across data collection methods
• EVIPNet Europe is filling a gap – there are no similar networks in Europe at present • Gaining commitment is challenging because it is difficult to demonstrate value for evidence-informed policy • Sharing stories of success from other countries or regions helps improve understanding of, and commitment to, EIP • Further sharing of the EVIPNet Europe vision at the country level is needed • Greater use of strategic levers and advocacy to gather commitment at a high level will help gain commitment and provide a clearer mandate for countries to join the network | • Substantial horizontal growth, with the Network growing from 13 countries initially to 21 within a few years • The current resources are insufficient to fully meet member countries’ needs; integration into other programme-specific work and the use of BCAsa to formalise the approach could help • The use of country cohortsb to facilitate cross-WHO work is a promising approach • Large variability in development of Network member countries, making training and multi-country meetings more challenging to organise • There are challenges to the sustainability of country work, with many countries still requiring WHO funding and further technical support • There is a lack of institutionalisation (vertical growth), no KTPs are yet established • EVIPNet Europe has established a structure but many stakeholders are not aware of the accountability processes, e.g. through M&E |
• The logical step-wise approach to, and methodology for, EIP are appreciated • The lack of a mandate (obligatory requirement) for EIP and associated products is a challenge for countries • The WHO Secretariat has developed five support instruments and resources to date, though some gaps for tools were highlighted • Technical capacity-building workshops and support instruments are an important part of the EVIPNet Europe approach and are valued, though more work is needed • Most communication is currently largely one way from the WHO Secretariat to member countries and the use of social network communication (Yammer) has decreased over time. Face-to face communication is important to establish and build relationships • Sharing and networking are important for sharing experiences and lessons learnt and for mentorship by other countries and regions | • Individuals, personalities and relationships are important; WHO country offices play an important facilitating role; lack of coordination between agencies can be a barrier • Staff turnover at the level of the WHO Secretariat, WHO country offices, Ministry of Health, national champions and at the political level is a challenge • Partnerships with external and internal collaborators have been established at the Regional level; however, formal partnerships at the country level are more limited • Human capacity and financial resources were raised as an issue for country teams as well as the Secretariat; country teams are often reliant on limited staff, without dedicated funding or terms of reference • To help compensate for limited human and financial resources, the WHO Secretariat has been successful in utilising organisational resources, including core funding for intercountry work, and BCA funds (unique to the European Region) for country-level worka |
BCA biennial collaborative agreement, EIP evidence-informed policy, KTP knowledge translation platforms, M&E monitoring and evaluation
a The BCAs express an official commitment, as a contractual arrangement between the Member State and WHO to undertake EVIPNet Europe-related KT activities
b The country cohorts are where a group of EVIPNet member countries work together on developing evidence briefs for policy for a particular issue (e.g. for antimicrobial resistance), supported by an external facilitator and complemented by guidance provided by the WHO Secretariat of EVIPNet and the programme team from WHO. This has allowed increased visibility and joint funding, increasing the resources available as well as inclusion in country BCAs and, therefore, within priority areas